5VB9 | Immune System Inhibitor | date | Mar 28, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Il-17a In Complex With Peptide | ||||||||||||||
authors | S.Antonysamy, M.Russell, A.Zhang, C.Groshong, D.Manglicmot, F.Lu, S.R.Wasserman, F.Zhang, S.Afshar, H.Bina, H.Broughton, M.Chalmer J.Dodge, A.Espada, S.Jones, J.P.Ting, M.Woodman | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Interleukin-17a Chain: A, B Fragment: Unp Residues 38-155 Synonym: Il-17a,Cytotoxic T-Lymphocyte-Associated Antigen 8 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Il17a, Ctla8, Il17 Expression_system: Baculovirus Expression Vector Pfastbac1- Expression_system_taxid: 274590 | ||||||||||||||
Molecule: Peptide Inhibitor Chain: C, D Engineered: Yes |
Synthetic: Yes Organism_scientific: Synthetic Construct Organism_taxid: 32630 | ||||||||||||||
symmetry | Space Group: P 21 21 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.70 Å | ||||||||||||
ligand | CL, EDO | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Utilization of peptide phage display to investigate hotspots on IL-17A and what it means for drug discovery., Ting JP, Tung F, Antonysamy S, Wasserman S, Jones SB, Zhang FF, Espada A, Broughton H, Chalmers MJ, Woodman ME, Bina HA, Dodge JA, Benach J, Zhang A, Groshong C, Manglicmot D, Russell M, Afshar S, PLoS One. 2018 Jan 12;13(1):e0190850. doi: 10.1371/journal.pone.0190850., eCollection 2018. PMID:29329326 |
Data retrieval |
View 5VB9 in 3D |
Visual 3D analysis of 5VB9 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5VB9 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |